Citadel Advisors
CRKN

Citadel Advisors’s Crown Electrokinetics Corp. Common Stock CRKN Stock Holding History

Citadel Advisors’s Portfolio CRKN Stock Details CRKN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-4
Closed -$11.9K – 15631
2023
Q4 		$11.9K Buy
4
+1
+33% +$5.27K ﹤0.01% 13018
2023
Q3 		$26K Buy
+3
New +$190K ﹤0.01% 12400
2022
Q3 		– Hold
0
– -$26K – 13818
2022
Q2 		– Hold
0
– – – 12298
2022
Q1 		– Hold
0
– -$98K – 14789
2021
Q4 		– Hold
0
– – – 12744
2021
Q2 		– Hold
0
– -$58K – 14601
2021
Q1 		– Hold
0
– – – 12829

Other funds holding CRKN

HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
CSS
Cubist Systematic Strategies Stamford, Connecticut $21B AUM 21.48% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
JF
Jump Financial Chicago, Illinois $7.5B AUM 33.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Citadel Advisors's CRKN Position: Q1 2024 in Review

Citadel Advisors sold out of Crown Electrokinetics Corp. Common Stock (CRKN) in Q1 2024, closing a stake of 4 shares — an estimated $11.9K sold.

Citadel Advisors first reported a position in CRKN in Q3 2023 and held it in 2 quarters. The position peaked at $26K in Q3 2023. 8 funds tracked by Wall St. Rank hold CRKN as of Q1 2024.

  • Citadel Advisors reported no remaining Crown Electrokinetics Corp. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Citadel Advisors sold 4 Crown Electrokinetics Corp. Common Stock shares in Q1 2024, an estimated $11.9K.
  • Citadel Advisors first reported a position in Crown Electrokinetics Corp. Common Stock in Q3 2023 and held it in 2 quarters.
  • Citadel Advisors's Crown Electrokinetics Corp. Common Stock position peaked at $26K in Q3 2023.
  • 8 funds tracked by Wall St. Rank held Crown Electrokinetics Corp. Common Stock as of Q1 2024.

Based on Citadel Advisors's 13F filing for Q1 2024, filed 15 May 2024.